Combination Latency Reversal With High Dose Disulfiram Plus Vorinostat in HIV-infected Individuals on ART (DIVA): A Single Arm Clinical Trial

Trial Profile

Combination Latency Reversal With High Dose Disulfiram Plus Vorinostat in HIV-infected Individuals on ART (DIVA): A Single Arm Clinical Trial

Suspended
Phase of Trial: Phase I/II

Latest Information Update: 11 Oct 2017

At a glance

  • Drugs Disulfiram (Primary) ; Vorinostat (Primary)
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Acronyms DIVA
  • Most Recent Events

    • 06 Oct 2017 Status changed from recruiting to suspended.
    • 31 Jul 2017 Status changed from not yet recruiting to recruiting.
    • 28 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top